scispace - formally typeset
M

Michael H. Rivner

Researcher at Georgia Regents University

Publications -  58
Citations -  2425

Michael H. Rivner is an academic researcher from Georgia Regents University. The author has contributed to research in topics: Myasthenia gravis & Amyotrophic lateral sclerosis. The author has an hindex of 20, co-authored 55 publications receiving 1997 citations. Previous affiliations of Michael H. Rivner include Duke University & Case Western Reserve University.

Papers
More filters
Journal ArticleDOI

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, +623 more
- 01 Dec 2017 - 
TL;DR: A phase 3, randomised, double-blind, placebo-controlled, multicentre study in 76 hospitals and specialised clinics across North America, Latin America, Europe, and Asia to assess the efficacy and safety of eculizumab in patients with refractory myasthenia gravis.
Journal ArticleDOI

Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy.

Jerry R. Mendell, +19 more
- 27 Feb 2001 - 
TL;DR: IVIg improves strength in patients with untreated CIDP by day 10 with continued benefit through day 42; more than one third improve by at least a functional grade on a disability scale.
Journal ArticleDOI

Influence of age and height on nerve conduction.

Michael H. Rivner, +2 more
- 01 Sep 2001 - 
TL;DR: Age and height were strongly inversely correlated with the amplitudes of both sensory and motor responses, accounting for 7–16% of the variance, and both height and age must be taken into consideration when normal values are developed.
Journal ArticleDOI

False positive electrodiagnostic tests in carpal tunnel syndrome

M D Redmond, +1 more
- 01 May 1988 - 
TL;DR: It appears that the comparison of the median to ulnar sensory latency across the carpal tunnel is of greatest potential value, but even here a more conservative difference of 0.5 msec between median and ulnar nerves must be used to avoid false positive tests for CTS.
Journal ArticleDOI

Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial.

Gil I. Wolfe, +324 more
- 01 Mar 2019 - 
TL;DR: At 5 years, thymectomy plus prednisone continues to confer benefits in patients with generalised non-thymomatous myasthenia gravis compared withprednisone alone, and the primary endpoints of the extension phase were the time-weighted means of the QMG score and alternate-day Prednisone dose from month 0 to month 60.